Phase II Clinical Trial of XTR004 as a Novel 18F-Labeled PET Myocardial Perfusion Tracer To Detect Flow-Limited Coronary Stenoses Confirmed by Quantitative Coronary Angiography and Fraction Flow Reserve

IF 3 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Nuclear Cardiology Pub Date : 2024-08-01 DOI:10.1016/j.nuclcard.2024.101982

Zhiming Yao MD/PhD , Mei Li MD , Jigang Yang MD , Bailing Hsu PhD

引用次数: 0

查看原文本刊更多论文

XTR004 作为一种新型 18F 标记 PET 心肌灌注示踪剂，用于检测通过定量冠状动脉造影和分数血流储备确认的血流受限型冠状动脉狭窄的 II 期临床试验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nuclear Cardiology 医学-核医学

CiteScore

5.30

自引率

20.80%

发文量

249

审稿时长

4-8 weeks

期刊介绍： Journal of Nuclear Cardiology is the only journal in the world devoted to this dynamic and growing subspecialty. Physicians and technologists value the Journal not only for its peer-reviewed articles, but also for its timely discussions about the current and future role of nuclear cardiology. Original articles address all aspects of nuclear cardiology, including interpretation, diagnosis, imaging equipment, and use of radiopharmaceuticals. As the official publication of the American Society of Nuclear Cardiology, the Journal also brings readers the latest information emerging from the Society''s task forces and publishes guidelines and position papers as they are adopted.